BenevolentAI Investors
BenevolentAI is a leading company that uses advanced AI technologies to accelerate biopharma drug discovery12. Here are some key points about BenevolentAI:End-to-End Drug Discovery: BenevolentAI offers end-to-end drug discovery services1. They are progressing five of their most advanced high-potential clinical and preclinical assets to their next inflection points1.Knowledge Exploration Tools: They have developed customizable SaaS products that enable scientists to make higher-confidence decisions and improve discovery and research productivity1.Collaborations: BenevolentAI has ongoing collaborations with leading pharma partners like AstraZeneca and Merck1. These collaborations aim to identify and develop innovative compounds for various diseases1.Listed Company: BenevolentAI is listed on the Euronext Amsterdam stock exchange3.Please note that this information is accurate as of the last update and for the most recent information, you may want to visit their official website1.Learn more:✕This summary was generated using AI based on multiple online sources. To view the original source information, use the "Learn more" links.1BenevolentAI | AI Drug Discovery | …benevolent.com2About us | BenevolentAI | AI Drug Discoverybenevolent.com3BenevolentAI - Crunchbase Com…crunchbase.com4BenevolentAI announces 3-year collaboration ex…prnewswire.com5BenevolentAI Signs Strategic Collaboratio…businesswire.comBenevolentAI | AI Drug Discovery | AI P…www.benevolent.com/About us | BenevolentAI | AI Drug Disco…www.benevolent.com/about-us/BenevolentAI - Crunchbase Company P…www.crunchbase.com/organization/benevolent-aiBenevolentAI announces 3-year collabo…www.prnewswire.com/news-releases/benevolentai …BenevolentAI Signs Strategic Collaborat…www.businesswire.com/news/home/202309190176…Feedback
